Literature DB >> 16705603

Biofilm formation in medical device-related infection.

D Mack1, H Rohde, L G Harris, A P Davies, M A Horstkotte, J K-M Knobloch.   

Abstract

Medical device-associated infections, most frequently caused by coagulase-negative staphylococci, especially Staphylococcus epidermidis, are of increasing importance in modern medicine. Regularly, antimicrobial therapy fails without removal of the implanted device. The most important factor in the pathogenesis of medical device-associated staphylococcal infections is the formation of adherent, multilayered bacterial biofilms. There is urgent need for an increased understanding of the functional factors involved in biofilm formation, the regulation of their expression, and the interaction of those potential virulence factors in device related infection with the host. Significant progress has been made in recent years which may ultimately lead to new rational approaches for better preventive, therapeutic, and diagnostic measures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705603     DOI: 10.1177/039139880602900404

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  44 in total

1.  Phenotypic and genotypic characterization of biofilm formation in Staphylococcus haemolyticus.

Authors:  Elaine M Barros; Moara Lemos; Thais Souto-Padrón; Marcia Giambiagi-deMarval
Journal:  Curr Microbiol       Date:  2015-02-28       Impact factor: 2.188

2.  Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report.

Authors:  Paul Stoodley; Laura Nistico; Sandra Johnson; Leslie-Ann Lasko; Mark Baratz; Vikram Gahlot; Garth D Ehrlich; Sandeep Kathju
Journal:  J Bone Joint Surg Am       Date:  2008-08       Impact factor: 5.284

3.  INVESTIGATION OF BIOFILM FORMATION IN COAGULASE-NEGATIVE STAPHYLOCOCCI ISOLATED FROM PLATELET CONCENTRATE BAGS.

Authors:  Rosiéli Martini; Rosmari Hörner; Roberta Filipini Rampelotto; Litiérri Razia Litiérri Garzon; Melise Silveira Nunes; Mayza Dalcin Teixeira; Daniel Ângelo Sganzerla Graichen
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

4.  Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein.

Authors:  Miriam A Banner; John G Cunniffe; Robin L Macintosh; Timothy J Foster; Holger Rohde; Dietrich Mack; Emmy Hoyes; Jeremy Derrick; Mathew Upton; Pauline S Handley
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

5.  Virulence factors associated with Coagulase Negative Staphylococci isolated from human infections.

Authors:  K R Soumya; Suja Philip; Sheela Sugathan; Jyothis Mathew; E K Radhakrishnan
Journal:  3 Biotech       Date:  2017-06-08       Impact factor: 2.406

Review 6.  Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms.

Authors:  K Keely Boyle; Stuart Wood; T David Tarity
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

7.  Purification, crystallization and preliminary X-ray diffraction analysis of the Staphylococcus epidermidis extracellular serine protease Esp.

Authors:  Krishnan Vengadesan; Kevin Macon; Shinya Sugumoto; Yoshimitsu Mizunoe; Tadayuki Iwase; Sthanam V L Narayana
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-12-20

8.  Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm.

Authors:  Ewa Szczuka; Adam Kaznowski
Journal:  Folia Microbiol (Praha)       Date:  2014-01-05       Impact factor: 2.099

9.  The role of activated acetate intermediates in the control of Escherichia coli biofilm amounts.

Authors:  Robert Mugabi; Daniel Sandgren; Megan Born; Ian Leith; Shelley M Horne; Birgit M Prüβ
Journal:  Webmedcentral       Date:  2012-07-18

10.  Biofilm formation by Staphylococcus haemolyticus.

Authors:  Elizabeth Gladys Aarag Fredheim; Claus Klingenberg; Holger Rohde; Stephanie Frankenberger; Peter Gaustad; Trond Flaegstad; Johanna Ericson Sollid
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.